• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ENDOLOGIX AFX; BIFURCATED STENT GRAFT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ENDOLOGIX AFX; BIFURCATED STENT GRAFT Back to Search Results
Model Number BA28-70/I16-30
Medical Device Problem Codes Loss of or Failure to Bond (1068); Leak/Splash (1354); Material Puncture/Hole (1504)
Health Effect - Clinical Code Failure of Implant (1924)
Date of Event 10/04/2018
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
The devices involved in the event will not be returned for evaluation, they remain implanted in the patient.If additional information pertinent to the incident is obtained, a follow-up report will be submitted.
 
Event or Problem Description
The patient was initially implanted with an afx device to treat an aneurysm.Recently the patent was presented with strata and a type 3 endoleak (indeterminate origin).As of the date of this report there have been no additional patient sequelae reported and secondary planned procedure is unknown.The patient status as unknown and no additional information was provided.
 
Additional Manufacturer Narrative
A clinical evaluation of the reported event could not be completed due to a lack of receipt of relevant medical records and/or imaging.Requests were made and no response was received.As such, event determination, off label conditions, related patient harms and patient disposition could not be independently assessed.The manufacturing lot review confirmed all devices met specifications prior to release.Endologix continues to investigate this event and similar events to ensure the highest quality and patient safety.A root cause investigation was carried out for all afx complaints having an identified failure mode of a type iiib endoleak.Endologix implemented the following corrective actions with the intent of reducing type iiib endoleak events; upgraded graft material (i.E.Duraply) and updates to the ifu and additional physician training.The change to duraply graft material and the ifu changes were put in place july 2014.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AFX
Common Device Name
BIFURCATED STENT GRAFT
Manufacturer (Section D)
ENDOLOGIX
2 musick
irvine CA 92618
MDR Report Key8053823
Report Number2031527-2018-00840
Device Sequence Number1787718
Product Code MIH
UDI-Device Identifier00818009013514
UDI-Public(01)00818009013514(17)150605
Combination Product (Y/N)N
Initial Reporter CountryGM
PMA/510(K) Number
P040002
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2015
Reporter Type Manufacturer
Report Source company representative,health
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 10/04/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date02/17/2018
Device Model NumberBA28-70/I16-30
Device Lot Number1314628-020
Was Device Available for Evaluation? No
Initial Date Received by Manufacturer 10/04/2018
Supplement Date Received by Manufacturer10/04/2018
Initial Report FDA Received Date11/08/2018
Supplement Report FDA Received Date12/31/2018
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
AFX-BIFURCATED STENT GRAFT-LOT:1314628020; AFX-VELA INFRARENAL:1260217-022
Outcome Attributed to Adverse Event Other;
-
-